Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction
- PMID: 1676563
- DOI: 10.1097/00000441-199107000-00003
Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction
Abstract
The Natural course of Graves' disease after subtotal thyroidectomy was studied in 67 patients who had subtotal thyroidectomy for Graves' disease and did not receive any medical treatment for 8 to 12 years after surgery. Postoperative thyroid status was determined by serum free thyroxine (T4), free triiodothyronine (T3), and thyrotropin (TSH) levels in the first period (1 year after surgery), second period (3.9 +/- 1.0 years), and third period (8.8 +/- 1.5 years). Serum thyroid stimulating antibody (TSAb) and TSH binding inhibitor immunoglobulin (TBII) activities were also measured. A total of 53 patients (79%) changed thyroid status during the observation period. One year after surgery, 50 percent of euthyroid subjects developed abnormal thyroid function in the next period. Reversible latent hypothyroidism was the most common type of thyroid dysfunction seen in up to 46% of patients. Interestingly, hyperthyroidism and hypothyroidism that developed in the postoperative period were temporary disorders in most cases. Serum TSAb and TBII activities did not help predict the postoperative changes of thyroid status. Our study indicates that the instability of the thyroid function is common after subtotal thyroidectomy.
Similar articles
-
Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.World J Surg. 1992 Jul-Aug;16(4):647-52; discussion 652-3. doi: 10.1007/BF02067345. World J Surg. 1992. PMID: 1357830
-
Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?World J Surg. 1999 Jul;23(7):727-31. doi: 10.1007/pl00012377. World J Surg. 1999. PMID: 10390595
-
Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.Thyroid. 1999 Oct;9(10):979-88. doi: 10.1089/thy.1999.9.979. Thyroid. 1999. PMID: 10560951
-
5: Diagnosis and management of hyperthyroidism and hypothyroidism.Med J Aust. 2004 Feb 16;180(4):186-93. doi: 10.5694/j.1326-5377.2004.tb05866.x. Med J Aust. 2004. PMID: 14960142 Review.
-
Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy.Best Pract Res Clin Endocrinol Metab. 2019 Aug;33(4):101319. doi: 10.1016/j.beem.2019.101319. Epub 2019 Aug 31. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31530446 Review.
Cited by
-
Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism.ScientificWorldJournal. 2012;2012:548796. doi: 10.1100/2012/548796. Epub 2012 Feb 1. ScientificWorldJournal. 2012. PMID: 22448136 Free PMC article.
-
Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.World J Surg. 2006 Nov;30(11):1950-6. doi: 10.1007/s00268-005-0770-x. World J Surg. 2006. PMID: 17006611
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical